Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: synthesis of findings from two multi-practice chart reviews in the United States-Reference-Cited by-同舟云学术

Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: synthesis of findings from two multi-practice chart reviews in the United States

Published:2014-08-27 Issue:11 Volume:30 Page:2343-2353
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Signorovitch James E.¹,Vogelzang Nicholas J.²,Pal Sumanta K.³,Lin Peggy L.¹,George Daniel J.⁴,Wong Michael K.⁵,Liu Zhimei⁶,Wang Xufang⁶,Culver Ken⁶,Scott Jeffrey A.⁷,Jonasch Eric⁸

Affiliation:

1. Analysis Group Inc. Boston, MAUSA

2. US Oncology Research, Comprehensive Cancer Centers of Nevada Las Vegas, NVUSA

3. City of Hope Comprehensive Cancer Center Duarte, CAUSA

4. GU Oncology, Duke Cancer Institute Durham, NCUSA

5. University of Southern California Norris Comprehensive Cancer Center Los Angeles, CAUSA

6. Novartis Pharmaceuticals Corporation East Hanover, NJUSA

7. Cardinal Health Grand Prairie, TXUSA

8. MD Anderson Cancer Center Houston, TXUSA

Publisher

Informa Healthcare

Subject